Dr. Reddy's launches novel drug for chronic constipation management
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
This project shall be implemented through incorporation of a new joint venture company in Zambia
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
The facility will be positioned as a Centre of Excellence for tertiary care services
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Subscribe To Our Newsletter & Stay Updated